Kellie R Machlus

28PUBLICATIONS
100CO-AUTHORS
Nanotoxicology, health and safetyHaematologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (28)

|Aug 11, 2026
Rethinking the selection of in vivo thrombosis models in the hybrid era.

|Dec 18, 2025
Platelet dysfunction in chronic kidney disease arises from bone marrow remodeling and megakaryocyte reprogramming.

Estelle Carminita, Virginia Camacho, Siobhan Branfield

|Dec 15, 2025
Major histocompatibility complex class II-expressing bone marrow megakaryocytes activate CD4+ T cells and induce regulatory T cell fate.

Virginia Camacho, Karen G Wang, Pavel Hanč

|Sep 24, 2025
CEBPA repression by MECOM blocks differentiation to drive aggressive leukemias.

Travis J Fleming, Mateusz Antoszewski, Sander Lambo

|Sep 12, 2025
Induction of moderate DNA damage enhances megakaryopoiesis and platelet production.

Virginia Camacho, Roelof H Bekendam, Andrew P Stone

|Jun 04, 2025
Induction of Moderate DNA Damage Enhances Megakaryopoiesis and Platelet Production.

Roelof H Bekendam, Virginia Camacho, Andrew P Stone

Pageof 5

Frequent Collaborators

6 joint publications

Joseph E Italiano

5 joint publications

Alisa S Wolberg

4 joint publications

Estelle Carminita

4 joint publications

Isabelle C Becker